SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alnylam Pharmaceuticals, Inc. (ALNY)
ALNY 456.04+1.4%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy8/15/2010 3:26:11 AM
   of 166
 
Note
Its in this months Popular Science and talks about
ALN-VSP and *suggests* the method might be useful for
any cancer.

+++++++++++++++++++++++
Hello Surf, There is an article in the September 2010 issue of Popular Science mag, page 35, that mentions this company several times.

I can't find a link to it on their site as they may not put latest issue stuff on there.

Title of article is "An Rx for every disease." Subtitle: "A protein killer could treat all cancers and possibly all illnesses."

Talks about small study of 19 liver cancer patients whose tumors did not respond to chemo, but an experimental RNAi drug cut off blood flow to 62% of their tumors.

Says conventional drugs stop disease-causing proteins, and the cited drug uses RNAi therapy to stop cells from making bad proteins in the first place, a tatic that could work for "hundreds of diseases." (pop sci's words)

Quotes company: Alnylam CEO saying, "Imagine that your kitchen floods, today's medicines mop it up. RNAi tech turns off the faucet."

Hope you are doing well.
+++++++++++++++++++++++

siliconinvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext